Back
Sarepta Therapeutics Quote, Financials, Valuation and Earnings
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
37
SRPT
Sarepta Therapeutics
Last Price:
115.54
Seasonality Move:
12.59%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.Sarepta Therapeutics Price Quote
$115.54
-0.08 (-0.83%)
(Updated: April 20, 2024 at 4:32 AM ET)
Sarepta Therapeutics Key Stats
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Day range:
$114.37 - $117.74
52-week range:
$55.25 - $159.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.59
P/B ratio:
12.63%
Volume:
622.2K
Avg. volume:
661.9K
1-year change:
-6.85%
Market cap:
$10.9B
Revenue:
$1.2B
EPS:
$-5.83
How Much Does Sarepta Therapeutics Make?
-
How Much Are Sarepta Therapeutics's Sales Annually?
SRPT Revenues are $1.2B -
How Much Profit Does Sarepta Therapeutics's Make A Year?
SRPT net income is -$536M
Is Sarepta Therapeutics Growing As A Company?
-
What Is Sarepta Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.54% -
What Is Sarepta Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sarepta Therapeutics Stock Price Performance
-
Did Sarepta Therapeutics Stock Go Up Last Month?
Sarepta Therapeutics share price went down by -6.8% last month -
Did SRPT's Share Price Rise Over The Last Year?
SRPT share price fell by -6.85% over the past 1 year
What Is Sarepta Therapeutics 52-Week High & Low?
-
What Is Sarepta Therapeutics’s 52-Week High Share Price?
Sarepta Therapeutics has traded as high as $159.89 over the past 52 weeks -
What Is Sarepta Therapeutics’s 52-Week Low Share Price?
Sarepta Therapeutics has traded as low as $55.25 over the past 52 weeks
Sarepta Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sarepta Therapeutics?
-
How Much Debt Does Sarepta Therapeutics Have?
Total long term debt quarterly is $1.2B -
How Much Cash Does Sarepta Therapeutics Have?
Cash and short term investments quarterly total is $1.7B -
What Is Sarepta Therapeutics’s Book Value Per Share?
Book value per share is 9.17
Is Sarepta Therapeutics Cash Flow Positive?
-
What Is SRPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$501M -
What Is Sarepta Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $125M -
What Is Sarepta Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$165.8M
Sarepta Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SRPT return on invested capital is -26.93% -
What Is Sarepta Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -17.08% -
What Is SRPT Return On Equity?
ROE is a measure of profitability and is -77.39%
Sarepta Therapeutics Earnings Date & Stock Price
-
What Is Sarepta Therapeutics's Stock Price Today?
A single share of SRPT can be purchased today for 115.62 -
What Is Sarepta Therapeutics’s Stock Symbol?
Sarepta Therapeutics trades on the nasdaq under the ticker symbol: SRPT -
When Is Sarepta Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sarepta Therapeutics is scheduled on May 2, 2024 -
When Is SRPT's next ex-dividend date?
Sarepta Therapeutics's next ex-dividend date is April 20, 2024 -
How To Buy Sarepta Therapeutics Stock?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sarepta Therapeutics Competitors
-
Who Are Sarepta Therapeutics's Competitors?
Below is a list of companies who compete with Sarepta Therapeutics or are related in some way:
Sarepta Therapeutics Dividend Yield
Data Unavailable
Sarepta Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 122.73% |
| Revenue: | 53.54% | 2.75% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 164.54 |
| Upside from Last Price: | 42.31% |